Literature DB >> 16476504

Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study.

Andreas Stang1, Hermann Pohlabeln, Klaus M Müller, Ingeborg Jahn, Klaus Giersiepen, Karl-Heinz Jöckel.   

Abstract

Only few studies have compared the agreement of histological lung carcinoma diagnosis of a population-based case series and an independent pathology review. We analyzed data of our population-based lung cancer case-control study to determine the agreement in the histopathological evaluation of lung cancer. Six-hundred and sixty-eight out of 1004 interviewed male and female lung cancer cases were histologically evaluated according to the 1981 WHO classification by regional pathologists and a central pathologist who was blinded to the evaluations of the regional pathologists. The observed agreement was 0.65 with kappa = 0.54 (95% CI: 0.49-0.58). It was highest for small-cell carcinoma (0.94; kappa = 0.82) and lower for squamous-cell carcinoma (0.81; kappa = 0.58) and adenocarcinoma (0.81; kappa = 0.55). Agreement was slightly higher among women than men. The observed agreement among non-smoking cases was 58% as compared to 67% heavy smoking cases. The moderate agreement for squamous-cell and adenocarcinoma complicates epidemiological studies that address these histological subtypes.

Entities:  

Mesh:

Year:  2006        PMID: 16476504     DOI: 10.1016/j.lungcan.2005.11.012

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  28 in total

1.  Clinical implications of genetic heterogeneity in multifocal pulmonary adenocarcinomas.

Authors:  Tawee Tanvetyanon; Theresa A Boyle
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.

Authors:  Kun-Hsing Yu; Feiran Wang; Gerald J Berry; Christopher Ré; Russ B Altman; Michael Snyder; Isaac S Kohane
Journal:  J Am Med Inform Assoc       Date:  2020-05-01       Impact factor: 4.497

3.  Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.

Authors:  Erik Thunnissen; Mary Beth Beasley; Alain C Borczuk; Elisabeth Brambilla; Lucian R Chirieac; Sanja Dacic; Douglas Flieder; Adi Gazdar; Kim Geisinger; Philip Hasleton; Yuichi Ishikawa; Keith M Kerr; Sylvie Lantejoul; Yoshiro Matsuno; Yuko Minami; Andre L Moreira; Noriko Motoi; Andrew G Nicholson; Masayuki Noguchi; Daisuke Nonaka; Giuseppe Pelosi; Iver Petersen; Natasha Rekhtman; Victor Roggli; William D Travis; Ming S Tsao; Ignacio Wistuba; Haodong Xu; Yasushi Yatabe; Maureen Zakowski; Birgit Witte; Dirk Joop Kuik
Journal:  Mod Pathol       Date:  2012-07-20       Impact factor: 7.842

4.  Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.

Authors:  Beate Pesch; Benjamin Kendzia; Per Gustavsson; Karl-Heinz Jöckel; Georg Johnen; Hermann Pohlabeln; Ann Olsson; Wolfgang Ahrens; Isabelle Mercedes Gross; Irene Brüske; Heinz-Erich Wichmann; Franco Merletti; Lorenzo Richiardi; Lorenzo Simonato; Cristina Fortes; Jack Siemiatycki; Marie-Elise Parent; Dario Consonni; Maria Teresa Landi; Neil Caporaso; David Zaridze; Adrian Cassidy; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Isabelle Stücker; Eleonora Fabianova; Rodica Stanescu Dumitru; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Charles M Rudin; Paul Brennan; Paolo Boffetta; Kurt Straif; Thomas Brüning
Journal:  Int J Cancer       Date:  2011-12-14       Impact factor: 7.396

5.  Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.

Authors:  Jun Shen; Feng Jiang
Journal:  Expert Opin Med Diagn       Date:  2012-05

6.  The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.

Authors:  Nehad M R Abd El-Maqsoud; Ehab Rifat Tawfiek; Ayman Abdelmeged; Mohamed Fathy Abdel Rahman; Alaa A E Moustafa
Journal:  Tumour Biol       Date:  2015-10-01

Review 7.  Omics Profiling in Precision Oncology.

Authors:  Kun-Hsing Yu; Michael Snyder
Journal:  Mol Cell Proteomics       Date:  2016-04-20       Impact factor: 5.911

8.  Lung cancer risk among hairdressers: a pooled analysis of case-control studies conducted between 1985 and 2010.

Authors:  Ann C Olsson; Yiwen Xu; Joachim Schüz; Jelle Vlaanderen; Hans Kromhout; Roel Vermeulen; Susan Peters; Isabelle Stücker; Florence Guida; Irene Brüske; Heinz-Erich Wichmann; Dario Consonni; Maria Teresa Landi; Neil Caporaso; Lap Ah Tse; Ignatius Tak-sun Yu; Jack Siemiatycki; Lesley Richardson; Dario Mirabelli; Lorenzo Richiardi; Lorenzo Simonato; Per Gustavsson; Nils Plato; Karl-Heinz Jöckel; Wolfgang Ahrens; Hermann Pohlabeln; Adonina Tardón; David Zaridze; Michael W Marcus; Andrea 't Mannetje; Neil Pearce; John McLaughlin; Paul Demers; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Rodica Stanescu Dumitru; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Paolo Boffetta; Cristina Fortes; Bas Bueno-de-Mesquita; Benjamin Kendzia; Thomas Behrens; Beate Pesch; Thomas Brüning; Kurt Straif
Journal:  Am J Epidemiol       Date:  2013-09-25       Impact factor: 4.897

9.  Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Authors:  Juneko E Grilley-Olson; D Neil Hayes; Dominic T Moore; Kevin O Leslie; Matthew D Wilkerson; Bahjat F Qaqish; Michele C Hayward; Christopher R Cabanski; Xiaoying Yin; Mark A Socinski; Thomas E Stinchcombe; Leigh B Thorne; Timothy Craig Allen; Peter M Banks; Mary B Beasley; Alain C Borczuk; Philip T Cagle; Rebecca Christensen; Thomas V Colby; Georgean G Deblois; Göran Elmberger; Paolo Graziano; Craig F Hart; Kirk D Jones; Diane M Maia; C Ryan Miller; Keith V Nance; William D Travis; William K Funkhouser
Journal:  Arch Pathol Lab Med       Date:  2012-05-14       Impact factor: 5.534

10.  A predictive phosphorylation signature of lung cancer.

Authors:  Chang-Jiun Wu; Tianxi Cai; Klarisa Rikova; David Merberg; Simon Kasif; Martin Steffen
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.